FDA Places Holds on Imfinzi Trials Following Unexplained Deaths in Keytruda Trials
News
The U.S. Food and Drug Administration (FDA) has placed a partial hold on two clinical trials testing a combination of AstraZeneca‘s Imfinzi (durvalumab) with an immunomodulatory drug in lymphoma and leukemia patients. ... Read more